Intellia Therapeutics, Inc. company logo
Intellia Therapeutics, Inc. logo

Intellia Therapeutics, Inc. (NTLA) Cash From Financing

Annual CFF

$185.75M$55.42M+42.53%

Summary

Current Value
As of today, NTLA annual cash from financing is $185.75M, up +42.53% on
Historical Performance
NTLA annual cash from financing is down -74.79% over the past 3 years, and up +143.02% over the past 5 years
All-Time High Comparison
NTLA annual cash from financing is currently -74.79% below its historical high of $736.69M set on
3-Year Low Comparison
NTLA annual cash from financing is +42.53% above its 3-year low of $130.32M reached on
Sector Comparison
NTLA annual cash from financing is higher than 89.21% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NTLA Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$185.75M+42.5%-74.8%+143.0%+1357.8%
Quarterly Cash From Financing$114.86M+39.7%+379.0%+10000.0%+2553.8%
TTM Cash From Financing$131.83M-54.5%+65.9%-16.2%+2945.9%
Price$11.74+20.6%-68.8%-85.9%
Annual Cash From Operations-$348.88M+11.5%-55.0%-237.9%-10000.0%
Annual Cash From Investing$125.57M+500.6%+122.8%+398.8%+10000.0%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$210.20M+82.2%+184.0%+1043.9%+100.0%
Shares Outstanding115.83M+13.5%+33.0%+74.9%

Cash From Financing Highs

NTLA Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$582.96MN/A-68.1%
5Y$736.69M-74.8%
All$736.69M-74.8%

Cash From Financing Lows

NTLA Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y$130.32M+42.5%
5Y$130.32M+42.5%
All$12.74M+1357.8%

Cash From Financing History

YearValueChange
$185.75M+42.5%
$130.32M-77.6%
$582.96M-20.9%
$736.69M+98.2%
$371.78M+386.4%
$76.43M+90.1%
YearValueChange
$40.22M-71.9%
$142.98M-14.5%
$167.30M+138.0%
$70.29M+451.6%
$12.74M-

FAQ

  • What is the current annual cash from financing of NTLA?

    As of today, NTLA annual cash from financing is $185.75M

  • What is 1-year change in NTLA annual cash from financing?

    NTLA annual cash from financing is up +42.53% year-over-year

  • What is 3-year change in NTLA annual cash from financing?

    NTLA annual cash from financing is down -74.79% over the past 3 years

  • How far is NTLA annual cash from financing from its all-time high?

    NTLA annual cash from financing is currently -74.79% below its historical high of $736.69M set on December 31, 2021

  • How does NTLA annual cash from financing rank versus sector peers?

    NTLA annual cash from financing is higher than 89.21% of companies in Healthcare sector

  • When is NTLA next annual earnings release?

    The next annual earnings release for NTLA is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. NTLA Official Website www.intelliatx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1652130/000119312525269680/0001193125-25-269680-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1652130/000095017025029007/0000950170-25-029007-index.htm
  4. NTLA Profile on Yahoo Finance finance.yahoo.com/quote/NTLA
  5. NTLA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ntla